Showing results (61-70 of 190) with videos related to
Sort By:
Pageof 19
Nature Communications|February 5, 2014
Critical roles of nardilysin in the maintenance of body temperature homoeostasisYoshinori Hiraoka, Tatsuhiko Matsuoka, Mikiko Ohno, et al.Cancer Chemotherapy and Pharmacology|August 18, 2010
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in TaiwanJen-Shi Chen, Yee Chao, Ruey-Kuen Hsieh, et al.Oncology Reports|January 14, 2004
Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphomaPo-Min Chen, Muh-Hwa Yang, Liang-Tsai Hsiao, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 2006
N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary dataPeng-Chan Lin, Ming-Yang Lee, Wei-Shu Wang, et al.Journal of the Chinese Medical Association : JCMA|April 6, 2013
Absolute lymphocyte count predicts response to rituximab-containing salvage treatment for relapsed/refractory B-cell non-Hodgkin's lymphoma with prior rituximab exposureMan-Hsin Hung, Yuan-Bin Yu, Liang-Tsai Hsiao, et al.Journal of the Chinese Medical Association : JCMA|July 17, 2014
Mast cell leukemia: an extremely rare diseaseDai-Yin Lu, Jyh-Pyng Gau, Ying-Chung Hong, et al.Annals of Hematology|March 11, 2008
High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphomaMing-Huang Chen, Liang-Tsai Hsiao, Tzeon-Jye Chiou, et al.Cancer|February 27, 2008
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinomaChun-Yu Liu, Po-Min Chen, Tzeon-Jye Chiou, et al.Cancer Medicine|July 10, 2018
Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown originHao-Yuan Wang, Ching-Fen Yang, Tzeon-Jye Chiou, et al.Journal of the Chinese Medical Association : JCMA|March 25, 2015
Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphomaSheng-Hsiang Yang, Liang-Tsai Hsiao, Tzeon-Jye Chiou, et al.Pageof 19